AMultifactorial mechanism in the superior antimalarial activity of α-C-GalCer

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Schmieg, John ^a,b   Yang, Guangli ^c,d   Franck, Richard W ^c   Tsuji, Moriya ^a,e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA C GALACTOSYLCERAMIDE; ALPHA GALACTOSYLCERAMIDE; ANTIMALARIAL AGENT; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; ALPHA-GALACTOSYLCERAMIDE; C GALACTOSYLCERAMIDE; C GLYCOSIDE; C-GALACTOSYLCERAMIDE; C-GLYCOSIDE; GALACTOSYLCERAMIDE; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; MONOSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIMALARIAL ACTIVITY; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; FEMALE; IN VIVO STUDY; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMODIUM YOELII; SPLEEN CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALARIA; METABOLISM;

PLASMODIUM YOELII; RODENTIA;

ANIMALS; ANTIMALARIALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELLS; DOWN-REGULATION; GALACTOSYLCERAMIDES; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; MONOSACCHARIDES; RECEPTORS, ANTIGEN, T-CELL; TH2 CELLS;

EID: 84855642317     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/283612     Document Type: Article

References (36)

1. V. Nussenzweig and R. S. Nussenzweig, "Rationale for the development of an engineered sporozoite malaria vaccine," Advances in Immunology, vol. 45, pp. 283-334, 1989. (Pubitemid 19195509)
2. J. Schmieg, G. Gonzalez-Aseguinolaza, and M. Tsuji, "The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites," Microbes and Infection, vol. 5, no. 6, pp. 499-506, 2003. (Pubitemid 36570477)
3. M. Kronenberg, "Toward an understanding of NKT cell biology: progress and paradoxes," Annual Review of Immunology, vol. 23, pp. 877-900, 2005. (Pubitemid 40563188)
4. M. Tsuji, "Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands," Cellular and Molecular Life Sciences, vol. 63, no. 16, pp. 1889-1898, 2006.
5. G. Gonzalez-Aseguinolaza, C. de Oliveira, M. Tomaska, et al., "α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 15, pp. 8461-8466, 2000. (Pubitemid 30639695)
6. J. Schmieg, G. Yang, R. W. Franck, and M. Tsuji, "Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide," Journal of Experimental Medicine, vol. 198, no. 11, pp. 1631-1641, 2003. (Pubitemid 37494156)
7. J. Schmieg, G. Yang, R. W. Franck, N. van Rooijen, and M. Tsuji, "Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 4, pp. 1127-1132, 2005. (Pubitemid 40170737)
8. S.-I. Fujii, K. Shimizu, H. Hemmi, et al., "Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 30, pp. 11252-11257, 2006. (Pubitemid 44156505)
9. G. Yang, J. Schmieg, M. Tsuji, and R. W. Franck, "The C-glycoside analogue of the immunostimulant α-galactosylceramide (KRN7000): synthesis and striking enhancement of activity," Angewandte Chemie International Edition, vol. 43, no. 29, pp. 3818-3822, 2004. (Pubitemid 39257501)
10. O. Brua-Romero, J. C. R. Hafalla, G. Gonzalez-Aseguinolaza, G.-I. Sano, M. Tsuji, and F. Zavala, "Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR," International Journal for Parasitology, vol. 31, no. 13, pp. 1499-1502, 2001. (Pubitemid 32947005)
11. P. Chomczynski and N. Sacchi, "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction," Analytical Biochemistry, vol. 162, no. 1, pp. 156-159, 1987. (Pubitemid 17064313)
12. M. J. Smyth, N. Y. Crowe, and D. I. Godfrey, "NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma," International Immunology, vol. 13, no. 4, pp. 459-463, 2001. (Pubitemid 32288543)
13. A. O'Garra and N. Arai, "The molecular basis of T helper 1 and T helper 2 cell differentiation," Trends in Cell Biology, vol. 10, no. 12, pp. 542-550, 2000.
14. S. Sharif, G. A. Arreaza, P. Zucker, et al., "Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes," Nature Medicine, vol. 7, no. 9, pp. 1057-1062, 2001. (Pubitemid 32937388)
15. A. K. Singh, M. T. Wilson, S. Hong, et al., "Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis, " Journal of Experimental Medicine, vol. 194, no. 12, pp. 1801-1811, 2001. (Pubitemid 34028659)
16. A. D'Andrea, M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri, "Interleukin 10 (IL-10) inhibits human lymphocyte interferon y-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells," Journal of Experimental Medicine, vol. 178, no. 3, pp. 1041-1048, 1993. (Pubitemid 23260442)
17. M. Aste-Amezaga, X. Ma, A. Sartori, and G. Trinchieri, "Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10," Journal of Immunology, vol. 160, no. 12, pp. 5936-5944, 1998. (Pubitemid 28298054)
18. K.-I. Seino, M. Harada, and M. Taniguchi, "NKT cells are relatively resistant to apoptosis," Trends in Immunology, vol. 25, no. 5, pp. 219-221, 2004. (Pubitemid 38501666)
19. M. T. Wilson, C. Johansson, D. Olivares-Villagomez, et al., "The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion," Proceedings of the National Academy of Sciences of the UnitedStatesofAmerica,vol. 100,no. 19,pp. 10913-10918, 2003. (Pubitemid 37140127)
20. N. Y. Crowe, A. P. Uldrich, K. Kyparissoudis, et al., "Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells," Journal of Immunology, vol. 171, no. 8, pp. 4020-4027, 2003. (Pubitemid 37238677)
21. M. Harada, K.-I. Seino, H. Wakao, et al., "Down-regulation of the invariant Va14 antigen receptor in NKT cells upon activation," International Immunology, vol. 16, no. 2, pp. 241-247, 2004. (Pubitemid 38195654)
22. J. Schumann, R. B. Voyle, B.-Y. Wei, and H. R. MacDonald, "Cutting edge: influence of the TCR V/3 domain on the avidity of CD1d: a-galactosylceramide binding by invariant Va14 NKT cells," Journal of Immunology, vol. 170, no. 12, pp. 5815-5819, 2003. (Pubitemid 36682558)
23. A. K. Stanic, R. Shashidharamurthy, J. S. Bezbradica, et al., "Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural TCR," Journal of Immunology, vol. 171, no. 9, pp. 4539-4551, 2003. (Pubitemid 37310569)
24. S. Valitutti, S. Muller, M. Cella, E. Padovan, and A. Lanza-vecchia, "Serial triggering of many T-cell receptors by a few peptide-MHC complexes," Nature, vol. 375, no. 6527, pp. 148-151, 1995.
25. + T cells," Journal of Experimental Medicine, vol. 185, no. 4, pp. 641-651, 1997. (Pubitemid 27098149)
26. J. L. Matsuda, L. Gapin, J. L. Baron, et al., "Mouse Va14i natural killer T cells are resistant to cytokine polarization in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8395-8400,2003. (Pubitemid 36842556)
27. H. Kitamura, K. Iwakabe, T. Yahata, et al., "The natural killer T (NKT) cell ligand a-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells," Journal of Experimental Medicine, vol. 189, no. 7, pp. 1121-1127, 1999. (Pubitemid 29169829)
28. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system," Journal of Immunology, vol. 163, no. 1, pp. 93-101, 1999. (Pubitemid 29295829)
29. Y.-F. Yang, M. Tomura, S. Ono, T. Hamaoka, and H. Fujiwara, "Requirement for IFN-y in IL-12 production induced by collaboration between Va14+ NKT cells and antigen-presenting cells," International Immunology, vol. 12, no. 12, pp. 1669-1675, 2000. (Pubitemid 32007723)
30. S.-I. Fujii, K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman, "Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein," Journal of Experimental Medicine, vol. 198, no. 2, pp. 267-279, 2003. (Pubitemid 36987852)
31. S.-I. Fujii, K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman, "The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation," Journal of Experimental Medicine, vol. 199, no. 12, pp. 1607-1618, 2004. (Pubitemid 38821994)
32. C. Rosette, G. Werlen, M. A. Daniels, et al., "The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model," Immunity, vol. 15, no. 1, pp. 59-70, 2001. (Pubitemid 32728320)
33. J. Sloan-Lancaster and P. M. Allen, "Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology," Annual Review of Immunology, vol. 14, pp. 1-27, 1996. (Pubitemid 26130175)
34. A. E. Nel and N. Slaughter, "T-cell activation through the antigen receptor. Part 2: role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy," Journal of Allergy and Clinical Immunology, vol. 109, no. 6, pp. 901-915, 2002. (Pubitemid 34634297)
35. S. Valitutti and A. Lanzavecchia, "Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition," Immunology Today, vol. 18, no. 6, pp. 299-304, 1997. (Pubitemid 27261450)
36. J. Rachmilewitz and A. Lanzavecchia, "A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding," Trends in Immunology, vol. 23, no. 12, pp. 592-595, 2002. (Pubitemid 35449098)